-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G83SwTRvNw8tpcKzimGQ4C1f4b3hb7ApmRoU2nH9+3KTNggj62kbwYKsBNcnuyeG Zer6hH9cz0bFsnUQ2KxxfA== 0000950136-03-000181.txt : 20030131 0000950136-03-000181.hdr.sgml : 20030131 20030131150136 ACCESSION NUMBER: 0000950136-03-000181 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20030130 FILED AS OF DATE: 20030131 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: SHERMAN BERNARD C CENTRAL INDEX KEY: 0000936837 RELATIONSHIP: OWNER FILING VALUES: FORM TYPE: 4 BUSINESS ADDRESS: STREET 1: HARTMAN & CRAVEN LLP STREET 2: 460 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 4167499300 MAIL ADDRESS: STREET 1: 150 SIGNET DR STREET 2: WESTON ONTARIO CITY: CANADA M9L 1T9 STATE: A6 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BARR LABORATORIES INC CENTRAL INDEX KEY: 0000010081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221927534 STATE OF INCORPORATION: NY FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09860 FILM NUMBER: 03534377 BUSINESS ADDRESS: STREET 1: 2 QUAKER RD BOX 2900 CITY: POMONA STATE: NY ZIP: 10970-0519 BUSINESS PHONE: 8453621100 MAIL ADDRESS: STREET 1: 2 QUAKER RD STREET 2: BOX 2900 CITY: POMONA STATE: NY ZIP: 10970-0519 4 1 file001.txt FORM 4 - ------------ FORM 4 - ------------ [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 ________________________________________________________________________________ 1. Name and Address of Reporting Person* Sherman Bernard C. - -------------------------------------------------------------------------------- (Last) (First) (Middle) c/o Apotex Holdings Inc. 150 Signet Drive - -------------------------------------------------------------------------------- (Street) Weston Ontario Canada M9L 1T9 - -------------------------------------------------------------------------------- (City) (State) (Zip) ________________________________________________________________________________ 2. Issuer Name and Ticker or Trading Symbol Barr Laboratories, Inc. (BRL) ________________________________________________________________________________ 3. I.R.S. Identification Number of Reporting Person, if an entity (Voluntary) ________________________________________________________________________________ 4. Statement for Month/Day/Year January 30, 2003 ________________________________________________________________________________ 5. If Amendment, Date of Original (Month/Day/Year) ________________________________________________________________________________ 6. Relationship of Reporting Person(s) to Issuer (Check all applicable) |_| Director |X| 10% Owner |_| Officer (give title below) |_| Other (specify below) ____________________________________________________________________ ________________________________________________________________________________ 7. Individual or Joint/Group Filing (Check Applicable Law) |_| Form Filed by One Reporting Person |X| Form Filed by More than One Reporting Person ________________________________________________________________________________ ================================================================================ TABLE I -- NON-DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED ================================================================================
5. Amount of 2A. Securities 6. 2. Deemed Beneficially Owner- Trans- Execution 3. 4. Owned ship 7. action Date, if Transaction Securities Acquired (A) or Following Form: Nature of Date any Code Disposed of (D) Reported (D) Direct Indirect 1. --------- --------- (Instr. 8) (Instr. 3 and 4) Transactions or (I) Beneficial Title of Security (Month/ (Month/ ------------ -------------------------- (Instr. 3 Indirect Ownership (Instr. 3) Day/Year) Day/Year) Code V Amount (A) or (D) Price and 4) (Instr.4) (Instr.4) - ----------------------------------------------------------------------------------------------------------------------------------- Common Stock 10,282,038 I By Sherman Delaware, Inc. - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- - ----------------------------------------------------------------------------------------------------------------------------------- ===================================================================================================================================
FORM 4 (CONTINUED) TABLE II -- DERIVATIVE SECURITIES ACQUIRED, DISPOSED OF, OR BENEFICIALLY OWNED (E.G., PUTS, CALLS, WARRANTS, OPTIONS, CONVERTIBLE SECURITIES) ================================================================================
9. Number 10. of Owner- deriv- ship ative Form 2. Secur- of Conver- 5. 7. ities Deriv- 11. sion Number of Title and Amount Bene- ative Nature or Derivative 6. of Underlying 8. ficially Secur- of Exer- 3A. 4. Securities Date Securities Price Owned ity: In- cise Deemed Trans- Acquired (A) Exercisable and (Instr. 3 and 4) of Follow- Direct direct Price 3. Execut- action or Disposed Expiration Date ---------------- Deriv- ing (D) or Bene- 1. of Trans- ion Code of(D) (Month/Day/Year) Amount ative Reported In- ficial Title of Deriv- action Date if (Instr. (Instr. 3, ---------------- or Secur- Trans- direct Owner- Derivative ative Date Any, 8) 4 and 5) Date Expira- Number ity actions (I) ship Security Secur- (Month/ (Month/ ------ ------------ Exer- tion of (Instr. (Instr. (Instr. (Instr. (Instr. 3) ity Day/Year)Day/Year)Code V (A) (D) cisable Date Title Shares 5) 4) 4) 4) - ------------------------------------------------------------------------------------------------------------------------------------ - ------------------------------------------------------------------------------------------------------------------------------------ ====================================================================================================================================
*If the Form is filed by more than one reporting person, See Instruction 4(b)(v). **Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). /s/ Bernard C. Sherman January 31, 2003 - --------------------------------------- ----------------- **Signature of the Reporting Person Date JOINT FILER INFORMATION This Form 4 is being filed jointly by the following parties: (i) Bernard C. Sherman ("Dr. Sherman"), who has sole voting and dispositive control, as the sole trustee, of the Bernard and Honey Sherman Trust ("Sherman Trust"), and who owns 99% of the outstanding capital stock of Sherman Holdings Inc. ("Sherman Holdings"); (ii) Sherman Trust which owns 99% of the common stock of Shermco, Inc. ("Shermco"); (iii) Sherman Holdings which owns 99% of the preferred stock of Shermco; (iv) Shermco which owns all of the outstanding capital stock of Sherfam Inc. ("Sherfam"); (v) Sherfam which owns all the outstanding capital stock of Apotex Holdings Inc. ("Apotex"); (vi) Apotex which owns all of the outstanding capital stock of SHERMFIN, INC. ("Shermfin"); (vii) Shermfin which owns all of the outstanding capital stock of Sherman Delaware, Inc ("SDI"); (viii) SDI which directly owns, as of the date of this filing, 11,382,038 shares of common stock of Barr Laboratories, Inc. Pursuant to Rule 16a-1(a)(4), the filing of this Form 4 shall not be deemed to be an admission by Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin that any of Dr. Sherman, Sherman Trust, Sherman Holdings, Shermco, Sherfam, Apotex and Shermfin is, for the purposes of Section 16 of the Securities Exchange Act of 1934, the beneficial owner of any securities covered by this Form 4. Name: Dr. Bernard C. Sherman Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Laboratories, Inc. (BRL) Date of Event Requiring Statement: January 30, 2003 /s/ Bernard C. Sherman Bernard C. Sherman
Name: Bernard and Honey Sherman Trust Name: Apotex Holdings Inc. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Laboratories, Inc. (BRL) Laboratories, Inc. (BRL) Date of Event Date of Event Requiring Statement: January 30, 2003 Requiring Statement: January 30, 2003 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------ ------------------ Bernard C. Sherman Bernard C. Sherman Sole Trustee President
Page 3 of 4
Name: Sherman Holdings Inc. Name: SHERMFIN, INC. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Laboratories, Inc. (BRL) Laboratories, Inc. (BRL) Date of Event Date of Event Requiring Statement: January 30, 2003 Requiring Statement: January 30, 2003 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------ ------------------ Bernard C. Sherman Bernard C. Sherman President President Name: Shermco Inc. Name: Sherfam Inc. Address: 150 Signet Drive, Weston, Address: 150 Signet Drive, Weston, Ontario, Canada M9L 1T9 Ontario, Canada M9L 1T9 Designated Filer: Sherman Delaware, Inc. Designated Filer: Sherman Delaware, Inc. Issuer and Ticker Symbol: Barr Issuer and Ticker Symbol: Barr Laboratories, Inc. (BRL) Laboratories, Inc. (BRL) Date of Event Date of Event Requiring Statement: January 30, 2003 Requiring Statement: January 30, 2003 By: /s/ Bernard C. Sherman By: /s/ Bernard C. Sherman ------------------- ------------------ Bernard C. Sherman Bernard C. Sherman Chairman Chairman
Page 4 of 4 -----END PRIVACY-ENHANCED MESSAGE-----